China Shineway Pharmaceutical Group Statistics

Total Valuation

China Shineway Pharmaceutical Group has a market cap or net worth of HKD 6.35 billion. The enterprise value is 30.66 million.

Market Cap	6.35B
Enterprise Value	30.66M

Important Dates

The next estimated earnings date is Friday, November 29, 2024.

Earnings Date	Nov 29, 2024
Ex-Dividend Date	Sep 10, 2024

Share Statistics

China Shineway Pharmaceutical Group has 755.40 million shares outstanding.

Current Share Class	n/a
Shares Outstanding	755.40M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	72.59%
Owned by Institutions (%)	6.02%
Float	207.04M

Valuation Ratios

The trailing PE ratio is 5.36 and the forward PE ratio is 5.28. China Shineway Pharmaceutical Group's PEG ratio is 0.57.

PE Ratio	5.36
Forward PE	5.28
PS Ratio	1.41
PB Ratio	0.81
P/TBV Ratio	n/a
P/FCF Ratio	5.88
P/OCF Ratio	n/a
PEG Ratio	0.57

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 0.03, with an EV/FCF ratio of 0.03.

EV / Earnings	0.03
EV / Sales	0.01
EV / EBITDA	0.03
EV / EBIT	0.03
EV / FCF	0.03

Financial Position

The company has a current ratio of 3.48, with a Debt / Equity ratio of 0.05.

Current Ratio	3.48
Quick Ratio	3.09
Debt / Equity	0.05
Debt / EBITDA	0.31
Debt / FCF	0.35
Interest Coverage	174.36

Financial Efficiency

Return on equity (ROE) is 15.81% and return on invested capital (ROIC) is 8.07%.

Return on Equity (ROE)	15.81%
Return on Assets (ROA)	6.29%
Return on Capital (ROIC)	8.07%
Revenue Per Employee	1.40M
Profits Per Employee	367,205
Employee Count	3,436
Asset Turnover	0.45
Inventory Turnover	1.28

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +29.10% in the last 52 weeks. The beta is 0.84, so China Shineway Pharmaceutical Group's price volatility has been lower than the market average.

Beta (5Y)	0.84
52-Week Price Change	+29.10%
50-Day Moving Average	8.92
200-Day Moving Average	8.80
Relative Strength Index (RSI)	31.57
Average Volume (20 Days)	858,090

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, China Shineway Pharmaceutical Group had revenue of HKD 4.52 billion and earned 1.19 billion in profits. Earnings per share was 1.57.

Revenue	4.52B
Gross Profit	3.40B
Operating Income	1.02B
Pretax Income	1.54B
Net Income	1.19B
EBITDA	1.19B
EBIT	1.02B
Earnings Per Share (EPS)	1.57

Full Income Statement

Balance Sheet

The company has 6.70 billion in cash and 377.21 million in debt, giving a net cash position of 6.32 billion or 8.37 per share.

Cash & Cash Equivalents	6.70B
Total Debt	377.21M
Net Cash	6.32B
Net Cash Per Share	8.37
Equity (Book Value)	7.88B
Book Value Per Share	10.44
Working Capital	6.48B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 1.26 billion and capital expenditures -182.31 million, giving a free cash flow of 1.08 billion.

Operating Cash Flow	1.26B
Capital Expenditures	-182.31M
Free Cash Flow	1.08B
FCF Per Share	1.43

Full Cash Flow Statement

Margins

Gross margin is 75.21%, with operating and profit margins of 22.47% and 26.27%.

Gross Margin	75.21%
Operating Margin	22.47%
Pretax Margin	34.04%
Profit Margin	26.27%
EBITDA Margin	26.28%
EBIT Margin	22.47%
FCF Margin	23.92%

Dividends & Yields

This stock pays an annual dividend of 0.58, which amounts to a dividend yield of 6.97%.

Dividend Per Share	0.58
Dividend Yield	6.97%
Dividend Growth (YoY)	23.35%
Years of Dividend Growth	1
Payout Ratio	36.93%
Buyback Yield	n/a
Shareholder Yield	6.97%
Earnings Yield	n/a
FCF Yield	n/a

Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

China Shineway Pharmaceutical Group has an Altman Z-Score of 3.84.

Altman Z-Score	3.84
Piotroski F-Score	n/a